[144] Coupang, Inc. SEC Filing

Rhea-AI Filing Summary

Coupang, Inc. (CPNG) Form 144 notice reports a proposed sale of 25,000 Class A common shares through J.P. Morgan Securities LLC on 08/28/2025, with an aggregate market value of $706,000. The shares were originally acquired on 11/01/2021 as vested restricted stock units granted by Coupang and were part of an equity compensation award totaling 150,131 shares acquired on that date.

The filing indicates no securities sold in the past three months and includes the standard attestation that the seller is not aware of undisclosed material adverse information. The broker, share counts, acquisition method, and sale date are explicitly reported.

Insights

Financial Analyst

TL;DR: Routine insider sale of vested RSUs through a broker; amount is modest relative to total outstanding shares, flagging low market impact.

The filing documents a sale of 25,000 shares valued at $706,000 executed via J.P. Morgan Securities. These shares were acquired from equity compensation (vesting of RSUs) on 11/01/2021. With 1,665,262,233 shares outstanding, the transaction represents a de minimis fraction of the float and is unlikely to affect valuation or market dynamics. The notice includes the required attestation regarding material non-public information and reports no other sales in the past three months, suggesting routine liquidity by an insider rather than a signal of operational issues.

Corporate Governance Expert

TL;DR: Compliance-focused filing showing sale of vested equity; disclosures appear complete and consistent with Rule 144 requirements.

The form identifies the broker, number of shares to be sold, acquisition date and nature (vesting of RSUs), and the approximate sale date. The seller affirms no undisclosed material adverse information and reports no recent sales in the prior three months. From a governance perspective, the disclosure follows expected procedures for Rule 144 transactions and provides transparent, specific details necessary for investor oversight. The size of the sale relative to outstanding shares suggests limited governance or market-signaling implications.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A Common Stock	J.P. Morgan Securities LLC 575 Washington Blvd Floor 9 Jersey City NJ 07310-1616	25000	706000	1665262233	08/28/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A Common Stock	11/01/2021	Vesting of Restricted Stock Units	Coupang, Inc. (issuer)			150131	11/01/2021	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What securities does Coupang insider plan to sell according to the Form 144?

The filer plans to sell 25,000 shares of Coupang Class A common stock through J.P. Morgan Securities LLC.

When were the shares being sold originally acquired?

The shares were acquired on 11/01/2021 through the vesting of restricted stock units granted by Coupang, Inc.

What is the aggregate market value and planned sale date reported?

The aggregate market value is reported as $706,000 with an approximate sale date of 08/28/2025.

Does the filing report any sales of Coupang securities in the past three months?

No. The Form 144 states Nothing to Report for securities sold during the past three months.

How many Coupang shares were outstanding per the filing?

The filing lists 1,665,262,233 shares outstanding.